生物活性 | |||
---|---|---|---|
描述 | Piperacillin sodium is a broad-spectrum β-lactam antibiotic[2]. At a concentration of 0. 1 mg/mL, piperacillin inhibited all streptococci except enterococci. At 25 mg/mL, piperacillin inhibited 95% of Pseudomonas aeruginosa and 78% of Bacteroides fragilis. Synergistic activity of piperacillin was demonstrated when it was combined with amikacin, gentamicin, and cefazolin against P. aeruginosa and members of the Enterobacteriaceae[3]. In addition, piperacillin causes mitochondrial dysfunction in neuron cells as shown by the reduction of mitochondrial respiration, membrane potential, and ATP production[4]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00435305 | - | Terminated(difficulties by enr... 展开 >>olling patients fundings consumed, no staff could be recruited and payed to continue enrolling patients,) 收起 << | November 2007 | Germany ... 展开 >> Universitäsklinikum Tübingen, Klinik für Anästhesiologie und Intensivmedizin Tübingen, Germany, 72076 收起 << | |
NCT01667094 | Cystic Fibrosis | Phase 4 | Active, not recruiting | July 2017 | Australia, Victoria ... 展开 >> The Alfred Hospital Melbourne, Victoria, Australia, 3181 收起 << |
NCT01066013 | Infections | Not Applicable | Unknown | June 2010 | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.85mL 0.37mL 0.19mL |
9.27mL 1.85mL 0.93mL |
18.53mL 3.71mL 1.85mL |
参考文献 |
---|